Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Brent, D. A. Articles by Keller, M. B. Search for Related Content PubMed Citation Articles by Brent, D. A. Articles by Keller, M. B. Child/Adolescent Psychiatry Depression Suicide Related Articles

Predictors of Spontaneous and Systematically Assessed Suicidal Adverse Events in the Treatment of SSRI-Resistant Depression in Adolescents (TORDIA) Study

OBJECTIVE: The authors sought to identify predictors of self-harm adverse events in treatment-resistant, depressed adolescents during the first 12 weeks of treatment. METHOD: Depressed adolescents (N=334) who had not responded to a previous trial with an SSRI antidepressant were randomized to a switch to either another SSRI or venlafaxine, with or without cognitive behavior therapy. Self-harm events, i.e., suicidal and non-suicidal self-injury adverse events were assessed by spontaneous report for the first 181 participants, and by systematic weekly assessment for the last 153 participants. RESULTS: Higher rates of suicidal (20.8% vs. 8.8%) and nonsuicidal self-injury (17.6% vs. 2.2%), but not serious adverse events (8.4% vs. 7.3%) were detected with systematic monitoring. Median time to a suicidal event was 3 weeks, predicted by high baseline suicidal ideation, family conflict, and drug and alcohol use. Median time to nonsuicidal self-injury was 2 weeks, predicted by previous history of nonsuicidal self-injury. While there were no main effects of treatment, venlafaxine treatment was associated with a higher rate of self-harm adverse events in those with higher suicidal ideation. Adjunctive use of benzodiazepines, while in a small number of participants (N=10) was associated with higher rate of both suicidal and nonsuicidal self-injury adverse events. CONCLUSIONS: Since predictors of suicidal adverse events also predict poor response to treatment, and many of these events occurred early in treatment, improving the speed of response to depression, by targeting of family conflict, suicidal ideation, and drug use may help to reduce their incidence. The relationship of venlafaxine and of benzodiazepines to self-harm events requires further study and clinical caution.

Related Articles:

Teenaged, Depressed, and Treatment Resistant: What Predicts Self-Harm?

Myrna M. Weissman
Am J Psychiatry 2009 166: 385. [Full Text] [PDF]

This article has been cited by other articles:

				E. SMITH TORDIA: Unique Opportunity to Explore Half-Life Theory Am J Psychiatry, August 1, 2009; 166(8): 936 - 936. [Full Text] [PDF]

				S. MOORE and J. COONEY Potential Limitations in Generalizing Findings From the TORDIA Study Am J Psychiatry, August 1, 2009; 166(8): 935 - 936. [Full Text] [PDF]

				D. A. BRENT, G. PORTA, and G. J. EMSLIE Dr. Brent, Ms. Porta, and Dr. Emslie Reply Am J Psychiatry, August 1, 2009; 166(8): 936 - 937. [Full Text] [PDF]

				M. M. Weissman Teenaged, Depressed, and Treatment Resistant: What Predicts Self-Harm? Am J Psychiatry, April 1, 2009; 166(4): 385 - 385. [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2009 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us